Is Immunomedics, Inc. (IMMU) A Good Stock To Buy?
At Insider Monkey, we pore over the filings of more than 700 top investment firms every quarter, a process we have now completed for the latest reporting period.
Immunomedics Inc (IMMU)
Market is closed
News
- First
- << Previous
- 31 - 36
Anika Therapeutics, Inc. (ANIK) Stands out Over Competition
Anika Therapeutics, Inc. (NASDAQ:ANIK) has quietly gone from being a complete unknown to recently being picked up by six hedge fund managers.
Immunomedics, Inc. (IMMU), ImmunoGen, Inc. (IMGN): Should You Invest in These Cancer Treatment Biotechs?
Today, cancer is the second leading cause of death in the United States, accounting for nearly a quarter of all deaths in the country.
Hedge Funds Are Betting On Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (NASDAQ:ANIK) was in 7 hedge funds' portfolio at the end of the first quarter of 2013.
Omthera Pharmaceuticals Inc (OMTH), GlaxoSmithKline plc (ADR) (GSK): This Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Biogen Idec Inc. (BIIB), Pharmacyclics, Inc. (PCYC), Immunomedics, Inc. (IMMU), and Tackling Cancer, Non-Hodgkin Lymphoma's Biggest Current & Upcoming Players
As I noted seven weeks ago, cancer statistics are both staggering and disappointing.
- First
- << Previous
- 31 - 36
Billionaire Hedge Funds
